ASKA Pharmaceutical Holdings Co Ltd 4886.T-JP:Tokyo Stock Exchange

*Data is delayed | JPY
Last | 04/09/21 JST
1,378.00quote price arrow up+1.00 (+0.07%)
Volume
43,100
52 week range
1,017.00 - 1,984.00

...

Loading . . .
  • Open1,377.00
  • Day High1,410.00
  • Day Low1,375.00
  • Prev Close1,377.00
  • 52 Week High1,984.00
  • 52 Week High Date12/07/20
  • 52 Week Low1,017.00
  • 52 Week Low Date04/06/20

Key Stats

  • Market Cap356.12M
  • Shares Out28.37M
  • 10 Day Average Volume82,690
  • Dividend14.00
  • Dividend Yield1.02%
  • Beta
  • YTD % Change-13.61

KEY STATS

  • Open1,377.00
  • Day High1,410.00
  • Day Low1,375.00
  • Prev Close1,377.00
  • 52 Week High1,984.00
  • 52 Week High Date12/07/20
  • 52 Week Low1,017.00
  • 52 Week Low Date04/06/20
  • Market Cap356.12M
  • Shares Out28.37M
  • 10 Day Average Volume82,690
  • Dividend14.00
  • Dividend Yield1.02%
  • Beta
  • YTD % Change-13.61

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date09/29/2020
  • Div Amount7.00
  • Split Date-
  • Split Factor-

Latest From ASKA Pharmaceutical Holdings Co Ltd

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
ASKA Pharmaceutical Co., Ltd. is a Japan-based company mainly engaged in the manufacture, sale, import and export of pharmaceutical products. The Company is engaged in the research, development and production of pharmaceutical products, including Altat, a remedy for peptic ulcer and gastritis, Prostal, a treatment for prostatic hypertrophy and cancer, Lipidil, a treatment for hyperlipidemia, Thyradin, a thyroid hormone drug, Ange, oral contraceptive agent, and Menoaid...
Takashi Yamaguchi
President
Address
2-5-1, Shibaura
Minato-ku, TKY
108-8532
Japan